David G. Soergel

2.7k citations

41 papers · 2.2k indexed · h-index 22

Impact in

Cellular and Molecular Neuroscience top 2%
- Neuropeptides and Animal Physiology
Anesthesiology and Pain Medicine top 2%
- Pain Management and Opioid Use

Papers in

Anesthesiology and Pain Medicine 7
- Pain Management and Opioid Use 6
Cardiology and Cardiovascular Medicine 17
- Heart Failure Treatment and Management 9
- Cardiac electrophysiology and arrhythmias 7

Co-authors: Jonathan D. Violin Michael W. Lark Franck Skobieranda Ruth Ann Subach Aimee L. Crombie David Burt Neil Singla Eugene R. Viscusi
Journals: Journal of Pain (4 papers)The Journal of Clinical Pharmacology (4 papers)American Journal of Physiology-Heart and Circulatory Physiology (3 papers)Circulation Heart Failure (2 papers)Journal of Cardiac Failure (2 papers)
Partner nations: United States Italy Greece

In The Last Decade

David G. Soergel

41 papers receiving 2.1k citations

Peers

Countries citing papers authored by David G. Soergel

Since Specialization

Citations

This map shows the geographic impact of David G. Soergel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Soergel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Soergel more than expected).

Fields of papers citing papers by David G. Soergel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Soergel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Soergel. The network helps show where David G. Soergel may publish in the future.

Co-authors

The 25 scholars most cited alongside David G. Soergel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David G. Soergel Line = papers co-authored together David G. Soergel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Centrally adjudicated vs. investigator-reported outcomes in randomized heart failure trials European Heart Journal ·Simon Wandel, Akshay S. Desai, Chien‐Wei Chen, John J.V. McMurray, Milton Packer, Scott D Solomon, Marc A. Pfeffer, G. Michael Felker, Faı̈ez Zannad, Mark C. Petrie, Pardeep S. Jhund, Zenab Attari, Guenther Mueller‐Velten, Martin Lefkowitz, David G. Soergel, Claudio Gimpelewicz	2024	2
2	New perspectives for hypertension management: progress in methodological and technological developments European Journal of Preventive Cardiology ·Gianfranco Parati, Alexandra Gonçalves, David G. Soergel, Rosa María Bruno, Enrico G. Caiani, Eva Gerdts, Felix Mahfoud, LG Mantovani, Richard J. McManus, Paola Santalucia, Thomas Kahan	2022	22
3	APOLLO‐2: A Randomized, Placebo and Active‐Controlled Phase III Study Investigating Oliceridine ( TRV 130), a G Protein–Biased Ligand at the μ‐Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty Pain Practice ·Neil Singla, Franck Skobieranda, David G. Soergel, Monica Salamea, David Burt, Mark A. Demitrack, Eugene R. Viscusi	2019	124
4	<p>APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy</p> Journal of Pain Research ·Eugene R. Viscusi, Franck Skobieranda, David G. Soergel, Emily A. Cook, David Burt, Neil Singla	2019	112
5	Is Plasma Renin Activity Associated with Worse Outcomes in Acute Heart Failure? A Secondary Analysis from the BLAST-AHF Trial European Journal of Heart Failure ·Rayan Jo Rachwan, Javed Butler, Sean P. Collins, Gad Cotter, Beth A. Davison, Stefanie Senger, Justin A. Ezekowitz, Gerasimos Filippatos, Phillip D. Levy, Marco Metra, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, Rudolf A. de Boer, David G. Soergel, G. Michael Felker, Peter S. Pang	2019	10
6	Relationship between baseline systolic blood pressure and long-term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF Clinical Research in Cardiology ·Gad Cotter, Beth A. Davison, Javed Butler, Sean P. Collins, Justin A. Ezekowitz, G. Michael Felker, Gerasimos Filippatos, Phillip D. Levy, Marco Metra, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, Stefanie Senger, David B. Bharucha, Kathleen Goin, David G. Soergel, Peter S. Pang	2017	33
7	Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF) European Heart Journal ·Peter S. Pang, Javed Butler, Sean P. Collins, Gad Cotter, Beth A. Davison, Justin A. Ezekowitz, Gerasimos Filippatos, Phillip D. Levy, Marco Metra, Piotr Ponikowski, John R. Teerlink, Adriaan A. Voors, David B. Bharucha, Kathleen Goin, David G. Soergel, G. Michael Felker	2017	107
8	Heart Failure Therapeutics on the Basis of a Biased Ligand of the Angiotensin-2 Type 1 Receptor JACC Heart Failure ·G. Michael Felker, Javed Butler, Sean P. Collins, Gad Cotter, Beth A. Davison, Justin A. Ezekowitz, Gerasimos Filippatos, Phillip D. Levy, Marco Metra, Piotr Ponikowski, David G. Soergel, John R. Teerlink, Jonathan D. Violin, Adriaan A. Voors, Peter S. Pang	2015	62
9	A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain Pain ·Eugene R. Viscusi, Lynn R. Webster, Michael E. Kuss, Stephen Daniels, James A. Bolognese, Seth Zuckerman, David G. Soergel, Ruth Ann Subach, Emily Cook, Franck Skobieranda	2015	169
10	Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers Pain ·David G. Soergel, Ruth Ann Subach, Nancy Burnham, Michael W. Lark, Ian E. James, Brian M. Sadler, Franck Skobieranda, Jonathan D. Violin, Lynn R. Webster	2014	220
11	Biased ligands at G-protein-coupled receptors: promise and progress Trends in Pharmacological Sciences ·Jonathan D. Violin, Aimee L. Crombie, David G. Soergel, Michael W. Lark	2014	290
12	First Clinical Experience with TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers The Journal of Clinical Pharmacology ·David G. Soergel, Ruth Ann Subach, Conrad L. Cowan, Jonathan D. Violin, Michael W. Lark	2013	68
13	TRVO27, A BETA-ARRESTIN BIASED LIGAND AT THE ANGIOTENSIN 2 TYPE 1 RECEPTOR, PRODUCES RAPID, REVERSIBLE CHANGES IN HEMODYNAMICS IN PATIENTS WITH STABLE SYSTOLIC HEART FAILURE Journal of the American College of Cardiology ·David G. Soergel, Ruth Ann Subach, Ian E. James, Conrad L. Cowan, Maxine Gowen, Michael W. Lark	2013	12
14	First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers The Journal of Clinical Pharmacology ·David G. Soergel, Ruth Ann Subach, Brian M. Sadler, John Connell, Alan Marion, Conrad L. Cowan, Jonathan D. Violin, Michael W. Lark	2013	103
15	First Human Dosing Experience with TRV130, a Biased Ligand at the Mu Opioid Receptor (P02.013) Neurology ·David G. Soergel, Ruth Ann Subach, Jonathan D. Violin, Dennis S. Yamashita, Maxine Gowen, Michael W. Lark	2013	1
16	GPCR biased ligands as novel heart failure therapeutics Trends in Cardiovascular Medicine ·Jonathan D. Violin, David G. Soergel, Guido Boerrigter, John C. Burnett, Michael W. Lark	2013	32
17	Cardiorenal Actions of TRV120027, a Novel ß-Arrestin–Biased Ligand at the Angiotensin II Type I Receptor, in Healthy and Heart Failure Canines Circulation Heart Failure ·Guido Boerrigter, Michael W. Lark, Erin J. Whalen, David G. Soergel, Jonathan D. Violin, John C. Burnett	2011	135
18	Augmented systolic response to the calcium sensitizer EMD-57033 in a transgenic model with troponin I truncation American Journal of Physiology-Heart and Circulatory Physiology ·David G. Soergel, Dimitrios Georgakopoulos, Linda B. Stull, David A. Kass, Anne M. Murphy	2004	10
19	Maitotoxin effects are blocked by SK&F 96365, an inhibitor of receptor-mediated calcium entry. PubMed ·David G. Soergel, T Yasumoto, John W. Daly, Fabian Gusovsky	1992	66
20	Effects of mastoparan and related peptides on phosphoinositide breakdown in HL-60 cells and cell-free preparations European Journal of Pharmacology Molecular Pharmacology ·Fabian Gusovsky, David G. Soergel, John W. Daly	1991	21

About David G. Soergel

David G. Soergel is a scholar working on Anesthesiology and Pain Medicine, Cardiology and Cardiovascular Medicine, Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 41 papers that have together received 2.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (20 papers), Heart Failure Treatment and Management (9 papers), Neuropeptides and Animal Physiology (9 papers), Cardiac electrophysiology and arrhythmias (7 papers), Pain Management and Opioid Use (6 papers), Pain Mechanisms and Treatments (6 papers), Pharmacological Receptor Mechanisms and Effects (5 papers) and Anesthesia and Pain Management (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (1.0k citations), Anesthesiology and Pain Medicine (237 citations), Cardiology and Cardiovascular Medicine (513 citations), Molecular Biology (1.4k citations) and Computational Theory and Mathematics (180 citations). David G. Soergel has collaborated with scholars based in United States, Italy and Greece. Frequent co-authors include Jonathan D. Violin, Michael W. Lark, Franck Skobieranda, Ruth Ann Subach, Aimee L. Crombie, David Burt, Neil Singla, Eugene R. Viscusi, John C. Burnett and Guido Boerrigter. Their work appears in journals such as Journal of Pain, The Journal of Clinical Pharmacology, American Journal of Physiology-Heart and Circulatory Physiology, Circulation Heart Failure and Journal of Cardiac Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact